What is the difference between Bronchogen and KPV?

Bronchogen: A short synthetic peptide bioregulator (Ala-Asp-Glu-Leu) from the Khavinson family, marketed for bronchial/respiratory tissue support. Evidence is largely Russian-language and preclinical.... KPV: KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH residues 11-13), the smallest alpha-MSH fragment retaining anti-inflammatory activity. Research-only; ...

Bronchogen vs KPV

Q: Can you stack Bronchogen and KPV?

Bronchogen (immune) and KPV (immune) are in the same category and may have overlapping mechanisms — researchers should review both profiles carefully before combining. Consult a licensed provider before combining any compounds.

Head-to-head comparison of Bronchogen and KPV — mechanism, dosing, side effects, legal status, and pricing.

Bronchogen

A short synthetic peptide bioregulator (Ala-Asp-Glu-Leu) from the Khavinson family, marketed for bronchial/respiratory tissue support. Evidence is largely Russian-language and preclinical.

Profile Prices Testing

KPV

KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (alpha-MSH residues 11-13), the smallest alpha-MSH fragment retaining anti-inflammatory activity. Research-only; not FDA-approved. Evidence is primarily preclinical with no controlled human trials.

Profile Prices Testing

Bronchogen

KPV

Where Researchers Are Buying

Live · updated daily

COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower

Bronchogen

Best $/mg

$3.50/mg

BioLongevity LabsC

2 trusted vendors listing

Compare all 2 vendors

KPV

Best $/mg

$2.10/mg

Peptide Supply Co.B

15 trusted vendors listing

Compare all 15 vendors

Lab Verification

COA corpus from Disclosed Labs — independently tested batches only.

Bronchogen

COAs

99.5%

Avg purity

Labs

Full testing data

KPV

COAs

99.5%

Avg purity

Labs

Full testing data

Bronchogen Research Summary

Primarily Russian institutional studies; no large independent controlled human trials.

KPV Research Summary

Dalmasso et al. (Gastroenterology 2008; PMID 18061177) demonstrated PepT1-mediated uptake of KPV and reduction of DSS- and TNBS-induced colitis in mice. Kannengiesser et al. (Inflammatory Bowel Diseases 2008; PMID 18092346) showed anti-inflammatory effects in two murine colitis models at least partly independent of MC1R signaling. Brzoska et al. (Endocrine Reviews 2008; PMID 18612139) reviewed alpha-MSH and related tripeptides, summarizing NF-kB suppression across cell types. Subsequent preclinical work (largely from the Merlin group at Georgia State) has explored oral nanoparticle and polysaccharide-hydrogel delivery for IBD. No controlled human trials have been published.

Key references

Can you stack Bronchogen and KPV?

Bronchogen and KPV are both in the Immune category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.

Other comparisons

BPC-157 vs KPV KPV vs TB-500 GHK-Cu vs KPV KPV vs Thymosin Alpha-1 KPV vs LL-37 KPV vs PEG-MGF GHK vs KPV AHK-Cu vs KPV

This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.